ПРЕПАРАТИ СЕЛЕНА В ТЕРАПЕВТИЧНОЇ ПРАКТИЦІ : ФАРМАКОЛОГІЧНІ ЕФЕКТИ У ХВОРИХ НА ПАНКРЕАТИТ НА ТЛІ ЦУКРОВОГО ДІАБЕТУ 2 ТИПУ
DOI:
https://doi.org/10.21856/j-PEP.2011.4.16Ключові слова:
Cелен, цукровий діабет, панкреатит, окседатівній стресАнотація
Медико-соціальна значимість досліджуваної проблеми багато в чому обумовлена значним рівнем інвалідності та смертності внаслідок розвитку пізніх ускладнень цукрового діабету 2 типу, яким страждає близько 3% населення України. При цукровому діабеті вдруге уражається як ендокринна, так і екзокринна функції підшлункової залози, приводячи до розвитку хронічного панкреатиту. Частота даної патології в загальній клінічній практиці становить від 0,2 до 0,6%.Посилання
Фадеенко, Г. Д. Селенсодержащие препараты в лечении больных хроническим панкреатитом [Текст] / Г. Д. Фадеенко, К.Ю. Дубров // Сучасна гастроентерологiя. — 2010. — № 5 (55). — С. 62–68.
Klotz, L. O. Role of copper, zinc, selenium and tellurium in the cellular defence against oxidative and nitrosative stress [Text] / L. O. Klotz, K. D. Kroncke, D. P. Buchczyk // J. Nutr. — 2003. — Vol. 133 (5 suppl. 1). — P. 1448S–1451S.
Abnormal drug metabolism in chronic pancreatitis: treatment with antioxidants [Text] / D. Sandilands, M. Jeffrey, N. Y. Haboubi [et al.] // HPB Surg. — 1999. — Vol. 11. — P. 207–216.
Громова, О. А. Селен — впечатляющие итоги и перспективы применения [Текст] / О. А. Громова, И. В. Гоголева // Трудный пациент. — 2007. — № 14. — С. 13–17.
Biochemical and histochemical studies of the selenium deficient pancreas in chicks [Text] / T. Noguchi, M. L. Langevin [et al.] // Department of Poultry Science and Graduate School of Nutrition, Cornell University, Ithaca, New York, 1974.
Zeng, J. Effect of selenium on pancreatic proinflammatory cytokines in streptozotocin induced diabetic mice [Text] / J. Zeng, J. Zhou, K. Huang // J. Nutr. Biochem. — 2005. — Vol. 20 (7). — P. 530–536.
Selenium stimulates pancreatic beta*cell gene expression and enhances islet function [Text] / S. C. Campbell, A. Aldibbiat, C. E. Marriott [et al.] // FEBS Lett. — 2008. — Vol. 582 (15). — P. 2333– 2337.
Винокурова, Л. В. Цитокиновый статус при хроническом панкреатите алкогольной и билиарной этиологии [Текст] / Л. В. Винокурова, П. С. Живаева, Т. М. Царегородцева // Тер. архив. — 2006. — № 78 (2). — С. 57–60.
Барабой, В. А. Селен в питании человека [Текст] / В. А. Барабой, Е. Н. Шестакова // Укр. бiохiм. журн. — 2004. — Т. 76, № 1. — С. 23–31.
Bjelakovic, G. Micronutrient antioxidant intake [Text] / Bjelakovic G. // Clin. Sci. — 2007. — Vol. 56. — P. 17–25.
The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society [Text] / P. Rosen, P. P. Nawroth,
G. King [et al.] // Diabet. Metabol. Res. Rev. — 2001. — № 17. — P. 189–212.
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 [Text] / J. C. Yoon, P. Puigserver, G. Chen [et al.] // Nature. — 2001. — № 413. — P. 131–138.
Deficiency in antioxidant factors in patients with alcohol-related chronic pancreatitis [Text] / A. V. Gossum, P. Closset, E. Noel [et al.] // Dig. Dis. Sci. — 2006. — № 41 (6). — P. 1225–1231.
An estimation of selenium requirements for New Zealanders[Text] / A. J. Duffield, C. D. Thomson, K. E. Hill, S. Williams // Am. J. Clin. Nutr. — 1999. — № 70. — P. 896–903.
Molecular mechanisms of insulin resistance [Text] / S. Schinner, W. A. Scherbaum, S. R. Bornstein, A. Barthel // Diabet. Med. — 2005. — № 22. — P. 674–682.
Insulin resistance and a diabetes mellituslike syndrome in mice lacking the protein kinase Akt2 (PKB beta) [Text] / H. Cho, J. Mu, J. K. Kim [et al.] // Science. — 2001. — № 292. — P. 1728–1731.
Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice [Text] / R. J. Gum, L. L. Gaede, S. L. Koterski [et al.] // Diabetes. — 2003. — № 52. — P. 21–28.
PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3 [Text] / S. H. Koo, H. Satoh, S. Herzig [et al.] // Nat. Med. — 2004. — № 10. — P. 530–534.
Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo [Text] / S. F. Previs, D. J. Withers, J. M. Ren [et al.] // J. Biol. Chem. — 2000. — № 275. — P. 38990–38994.
Puigserver, P. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction [Text] / P. Puigserver, J. Rhee, J. Donovan [et al.] // Nature. — 2003. — № 423. — P. 550–555.
Ezaki, O. The insulin-like effects of selenate in rat adipocytes [Text] / O. Ezaki // J. Biol. Chem. — 1990. — № 265. — P. 1124–1128.
Metabolic effect of sodium selenite: insulin-like inhibition of glucagon-stimulated glycogenolysis in the isolated perfused rat liver [Text] / M. Roden, M. Prskavec, C. Furnsinn [et al.] // Hepatology. — 1995. — № 22. — P. 169–174.
Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes [Text] / Y. J. Hei, S. Farahbakhshian, X. Chen [et al.] // Mol. Cell. Biochem. — 1999. — № 178. — P. 367– 375.
Selenite suppresses hydrogen peroxide-induced cell apoptosis through inhibition of ASK1/JNK and activation of PI3-K/Akt pathways [Text] / S. O. Yoon, M. M. Kim, S. J. Park // FASEB J. — 2002. — № 16. — P. 111–113.
Selenite-induced survival of HuH7 hepatoma cells involves activation of focal adhesion kinasephosphatidylinositol 3-kinase-Akt pathway and Rac1 [Text] / Y. C. Lee, Y. C. Tang, Y. H. Chen [et al.] // J. Biol. Chem. — 2003. — № 278. — P. 39615– 39624.
Selenium and diabetes: an enigma? [Text] / A. S. Mueller, K. Mueller, N. M. Wolf, J. Pallauf // Free Radic. Res. — 2009. — № 43. — P. 1029–1059.
Steinbrenner, H. Protection against reactive oxygen species by selenoproteins [Text] / H. Steinbrenner, H. Sies // Biochim. Biophys. Acta. — 2009. — № 1790. — P. 1478–1485.
Plasma selenium in patients with cirrhosis[Text] / R. F. Burk, D. S. Early, K. E. Hill [et al.] // Hepatology. — 1998. — № 27. — P. 794–798.
Serum selenium concentrations and diabetes in US adults. National Health and Nutrition Examination Survey (NHANES) 2003–2004 [Text] / M. Laclaustra, A. Navas-Acien, S. Stranges [et al.] // Environ. Healt. Perspect. — 2009. — № 117. — P. 1409–1413.
Serum selenium and serum lipids in US adults: National Health and Nutrition Examination Survey (NHANES) 2003–2004 [Text] / M. Laclaustra, A. Navas-Acien, S. Stranges [et al.] // Atherosclerosis. — 2010. — № 210. — P. 643–648.
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) [Text] / S. M. Lippman, E. A. Klein, P. J. Goodman [et al.] // JAMA. — 2009. — № 301. — P. 39–51.
Higher selenium status is associated with adverse blood lipid profile in British adults [Text] / S. Stranges, M. Laclaustra, C. Ji [et al.]
// J. Nutr. — 2010. — № 140. — P. 81–87.
Goldstein, B. J. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets [Text] / B. J. Goldstein, K. Mahadev, X. Wu // Diabetes. — 2005. — № 54. — P. 311–321.
The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction [Text] / K. Mahadev, H. Motoshima, X. Wu [et al.] // Mol. Cell. Biol. — 2004. — № 24. — P. 1844–1854.
Insulin-stimulated hydrogen peroxide reversibly inhibits proteintyrosine phosphatase 1B in vivo and enhances the early insulin action cascade [Text] / K. Mahadev, A. Zilbering, L. Zhu, B. J. Goldstein // J. Biol. Chem. — 2001. — № 276. — P. 21938–21942.
Antioxidants prevent healthpromoting effects of physical exercise in humans [Text] / M. Ristow, K. Zarse, A. Oberbach [et al.] // Proc. Natl. Acad. Sci. USA. — 2009. — № 106. — P. 8665–8670.
Cell death caused by selenium deficiency and protective effect of antioxidants [Text] / Y. Saito, Y. Yoshida, T. Akazawa [et al.] // J. Biol. Chem. — 2003. — № 278. — P. 39428–39434.
Involvement of selenoprotein P in protection of human astrocytes from oxidative damage [Text] / H. Steinbrenner, L. Alili, E. Bilgic [et al.] // Free Radic. Biol. Med. — 2006. — № 40. — P. 1513–1523.
Selenoprotein, P protects endothelial cells from oxidative damage by stimulation of glutathione peroxidase expression and activity [Text] / H. Steinbrenner, E. Bilgic, L. Alili [et al.] // Free Radic. Res. — 2006. — № 40. — P. 936–943.
Brigelius-Flohe, R. Tissue–specific functions of individual glutathione peroxidases [Text] / BrigeliusFlohe R. // Free Radic. Biol. Med. — 1999. — № 27. — P. 951–965.
Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase [Text] / J. P. McClung, C. A. Roneker, W. Mu [et al.] // Proc. Natl. Acad. Sc. USA. — 2004. — № 101. — P. 8852–8857.
Molecular mechanisms for hyperinsulinaemia induced by overproduction of selenium-dependent glutathione peroxidase-1 in mice [Text] / X. D. Wang, M. Z. Vatamaniuk, S. K. Wang [et al.] // Diabetologia. — 2008. — № 51. — P. 1515–1524.
Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells[Text] / M. Tiedge, S. Lortz, J. Drinkgern, S. Lenzen // Diabetes. — 1997. — № 46. — P. 1733–1742.
Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes [Text] / S. Lortz, M. Tiedge, T. Nachtwey [et al.] // Diabetes. — 2000. — № 49. — P. 1123–1130.
Overexpression of glutathione peroxidase with two isoforms of superoxide dismutase protects mouse islets from oxidative injury and improves islet graft function [Text] / T. B. Mysore, T. A. Shinkel, J. Collins [et al.] // Diabetes. — 2005. — № 54. — P. 2109–2116.
Redox regulation of protein tyrosine phosphatase 1B by manipulation of dietary selenium affects the triglyceride concentration in rat liver [Text] / A. S. Mueller, S. D. Klomann, N. M. Wolf [et al.] // J. Nutr. — 2008. — № 138. — P. 2328–2336.
Coordinated action of protein tyrosine phosphatases in insulin signal transduction [Text] / A. Cheng, N. Dube, F. Gu, M. L. Tremblay // Europ. J. Biochem. — 2002. — № 269. — P. 1050–1059.
Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial [Text] / R. Hurst, C. N. Armah, J. R. Dainty [et al.] // Am. J. Clin. Nutr. — 2010. — № 91. — P. 923– 931.
Effectiveness of selenium supplements in a low-selenium area of China [Text] / Y. Xia, K. E. Hill, D.W. Byrne [et al.] // Am. J. Clin. Nutr. — 2005. — № 81. — P. 829–834.
Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues [Text] / L. Schomburg, U. Schweizer, B. Holtmann [et al.] // Biochem J. — 2003. — № 370. — P. 397–402.
Optimization of selenoprotein P and other plasma selenium biomarkers for the assessment of the selenium nutritional requirement: a placebo-controlled double-blind study of selenomethionine supplementation in selenium-deficient Chinese subjects [Text]
/ Y. Xia, K. E. Hill, P. Li [et al.] // Am. J. Clin. Nutr. — 2010. — № 92. — P. 525–531.
Stimulation of selenoprotein P promoter activity in hepatoma cells by FoxO1a transcription factor [Text] / P. L. Walter, H. teinbrenner, A. Barthel, L. O. Klotz // Biochem. Biophys. Res. Commun. — 2008. — № 365. — P. 316–321.
Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis [Text] / J. Rhee, Y. Inoue, J. C. Yoon [et al.] // Proc. Natl. Acad. Sci. USA. — 2003. — № 100. — P. 4012–4017.
Serum selenium and serum lipids in US adults [Text] / J. Bleys, A. Navas-Acien, S. Stranges [et al.] // Am. J. Clin. Nutr. — 2008. — № 88. — P. 416– 423.
Bleys, J. Serum selenium and diabetes in US adults [Text] / J. Bleys, A. Navas-Acien, E. Guallar // Diabetes Care. — 2007. — № 30. — P. 829–834.
May, J. M. Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells [Text] // J. Biol. Chem. — 1979. — № 254. — P. 2214– 2220.
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 [Text] / S. Wild, G. Roglic, A. Green [et al.] // Diabetes Care. — 2004. — № 27. — P. 1047–1053.
Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial [Text] / S. Stranges, J. R. Marshall, R. Natarajan [et al.] // Ann. Intern. Med. — 2007. — № 147. — P. 217–223.
ISSN 
ISSN 
